Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma
Open Access
- 15 September 2001
- Vol. 92 (6) , 1468-1474
- https://doi.org/10.1002/1097-0142(20010915)92:6<1468::aid-cncr1471>3.0.co;2-s
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Monitoring of bone metastasesEuropean Journal Of Cancer, 1998
- Biochemical Markers of Bone Metabolism: An OverviewClinical Biochemistry, 1997
- Correlation Between Bone Metabolic Markers and Bone Scan in Prostatic CancerJournal of Urology, 1997
- Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatmentCancer Treatment Reviews, 1996
- Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.Journal of Clinical Oncology, 1996
- Weekly chemotherapy in advanced prostatic cancerBritish Journal of Cancer, 1993
- Prostate Specific Antigen and Bone Scan Correlation in the Staging and Monitoring of Patients with Prostatic CancerPublished by Wiley ,1992
- Prostate Specific Antigen in Hormonally Treated Stage D2 Prostate Cancer: Is it always an Accurate Indicator of Disease Status?Journal of Urology, 1991
- Coupling of bone formation to bone resorption: A broader viewCalcified Tissue International, 1984
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977